Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
Titel:
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
Auteur:
de Botton, Stéphane Montesinos, Pau Schuh, Andre C. Papayannidis, Cristina Vyas, Paresh Wei, Andrew H. Ommen, Hans Semochkin, Sergey Kim, Hee-Je Larson, Richard A. Koprivnikar, Jaime Frankfurt, Olga Thol, Felicitas Chromik, Jörg Byrne, Jenny Pigneux, Arnaud Thomas, Xavier Salamero, Olga Vidriales, Maria Belen Doronin, Vadim Döhner, Hartmut Fathi, Amir T. Laille, Eric Yu, Xin Hasan, Maroof Martin-Regueira, Patricia DiNardo, Courtney D.